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Summary Neonatal and infantile erythroderma is a diagnostic and 
therapeutic challenge. Numerous underlying causes have been 
reported. Etiologic diagnosis of erythroderma is frequently difficult to 
establish, and is usually delayed, due to the poor specificity of clinical 
and histopathologic signs. Differential diagnosis of erythroderma is 
a multi-step procedure that involves clinical assessment, knowledge 
of any relevant family history and certain laboratory investigations. 
Immunodeficiency must be inspected in cases of severe erythroderma 
with alopecia, failure to thrive, infectious complications, or evocative 
histologic findings. The prognosis is poor with a high mortality rate 
in immunodeficiency disorders and severe chronic diseases such as 
Netherton’s syndrome.
Key wordS:  erythroderma, neonatal, infantile, generalized 
exfoliative dermatitis
IntroduCtIon
 Erythroderma is defined as an inflammatory 
skin disorder affecting total or near total body sur-
face with erythema and/or moderate to extensive 
scaling (1). It is a reaction pattern of the skin that 
can complicate many underlying skin conditions at 
any age. In neonatal period it can be the primary 
manifestation of numerous conditions (2). How-
ever, some disorders in infants may initially be lo-
calized and then eventually develop into extensive 
erythroderma (1). Differential diagnosis includes 
benign transient, inflammatory, infectious, meta-
bolic and immune diseases, many of which have 
a hereditary basis. Some of these diseases are 
potentially life threatening, and erythroderma itself 
can cause serious medical complications such as 
electrolyte imbalance, hypoproteinemia, dehydra-
tion, sepsis, and temperature instability (3).
Neonatal and infantile erythroderma is a diag-
nostic and therapeutic challenge. Erythrodermic 
neonates and infants are frequently misdiagnosed 
with eczema and inappropriate topical steroid 
treatment can lead to Cushing syndrome. Delay 
in the establishment of the correct diagnosis can 
be fatal. Differential diagnosis of erythroderma is a 
multi-step procedure that involves clinical assess-
ment, knowledge of any relevant family history, 
and certain laboratory investigations (2). 
Laboratory investigations 
Differential diagnosis of erythroderma can 
be facilitated by some laboratory tests (Table 1). 
Serum IgE levels are profoundly increased in 
Netherton’s and Omenn’s syndromes, and mild-
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ly increased in early atopic eczema. Appropriate 
smears for potassium hydroxide (KOH) stain, 
Gram stain, Tzanck test as well as cultures for 
fungal, bacterial, or viral diseases should be per-
formed if infection is suspected. Chest radiograph 
may be useful to evaluate thymic shadow, which 
may be absent in neonates with severe combined 
immunodeficiency (SCID) (3). Serum electrolyte 
and albumin concentrations should be measured 
because children with erythroderma are at a risk 
of hypernatremic dehydration as well as enteral 
and transcutaneous protein losses. Complete 
blood count should be supplemented by more de-
tailed immunologic studies if Omenn’s syndrome 
or graft-versus-host disease is suspected (2). 
Serum amino and urine organic acids should be 
determined if primary metabolic diseases such as 
aminoaciduria or biotin deficiency are suspected. 
Biotinidase level can be obtained if biotin deficien-
cy is suspected (3).
HIStoLogy 
As it is very important to establish the diag-
nosis rapidly, it is advisable to take two or three 
simultaneous skin biopsies from different sites. 
Histology and immunohistochemistry can dif-
ferentiate Omenn’s from Netherton’s syndrome 
and other ichthyoses. Fibroblast culture from bi-
opsy can help reach definitive diagnosis of several 
metabolic diseases (3). Non-bullous and bullous 
ichthyosiform erythroderma are distinguishable 
on histology (4). In the graft-versus-host reaction, 
histology is valuable in severe cases, but in milder 
cases only some of the findings may be present 
and the diagnosis can easily be missed. In blister-
ing diseases, it is helpful to take biopsy from the 
border of the blister, including its roof, to facilitate 
assessment of the level of cleavage (2).
It is helpful to divide the subject of neonatal 
erythroderma into several categories, roughly ac-
cording to pathogenesis (Table 2). 
table 1. Laboratory investigations in neonatal and 
infantile erythroderma
1. Potassium hydroxide (KOH) stain for demon-
stration of mycelia/spores and fungal culture
2. Gram’s stain for bacteria and bacterial culture
3. Tzanck test 
4. Demonstration of Sarcoptes scabiei
5. Microscopic analysis of hair shaft abnormali-
ties
6. Complete hemogram
7. Skin biopsy for microscopic pathology 
8. Serum zinc and alkaline phosphatase levels
9. Sweat chloride levels 
10. Lipid profile including essential fatty acid lev-
els
11. Evaluation of humoral and cellular immunity; 
IgA, IgG, IgM, IgE, complement component, T 
and B lymphocytes  
12. Biotinidase/holocarboxylase synthetase levels
13. Plasma amino acid levels and urine organic 
acids 













Staphylococcal scalded skin syndrome (SSSS)
Congenital and neonatal candidiasis
Congenital herpes simplex infection 
Syphilis






Essential fatty acid deficiency
Amino acid disorders
Disorders of biotin metabolism
Immune disorders
Graft versus host disease (GVHD)
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tranSIent neonataL dermatoSeS
erythema toxicum neonatorum (etn) is the 
most common transient benign rash in healthy ne-
onates. The incidence is controversial, and ranges 
from 30% to 70% in various surveys. The cause of 
ETN has not yet been established (5). The pres-
ence of ETN correlates well with birth weight and 
gestational age. It is virtually never seen in pre-
mature infants or those weighing less than 2500 
g (6).  
Congenital lesions may occur, but the majority 
of cases have the onset between 24 and 48 hours 
of life. Lesions wax and wane, usually lasting for 
a week or less, but cases lasting beyond 2 weeks 
of life have been reported. It is characterized by 
small erythematous macules with or without cen-
tral papule or pustule, measuring 1 to 3 mm in di-
ameter, which may appear first on the face and 
spread to the trunk and proximal extremities, but 
may appear anywhere on the body except for the 
palms and soles (Fig. 1a) (5,6). Although the char-
acteristic lesions of ETN are usually discrete and 
scattered, extensive cases with confluent papules, 
or pustules with surrounding erythema forming 
erythematous plaques can occur and be more dif-
ficult to diagnose (Fig. 1b). Peripheral eosinophilia 
has also been associated in about 15% of cases 
(6). Skin biopsy is rarely needed. The diagnosis of 
ETN can usually be made by clinical appearance 
alone, but scraping of the pustule will reveal eosin-
ophils with a few scattered neutrophils. No therapy 
is needed, for ETN resolves spontaneously (5,6). 
mILIarIa  
The term miliaria is used to describe a group 
of transient eccrine disorders. Miliaria is common 
in summer months and is also noted in infants 
housed in incubators (5). There are three forms 
of miliaria due to occlusion of sweat ducts at vari-
ous levels, resulting in leakage of sweat in the epi-
dermis or papillary dermis. Only miliaria rubra can 
progress to erythroderma, mostly in hot and humid 
conditions (5,6). Miliaria rubra occurs between the 
11th and 15th day of life and it usually affects sites 
of friction or occlusion such as the neck and face, 
but also occurs on the trunk. Lesions are erythem-
atous, non-follicular papules or papulovesicles of 
1-3 mm in size (6).
CutaneouS dISorderS
atopic dermatitis 
Atopic dermatitis (AD) presents within the first 
6 months of life in 60% of children. Severe gener-
alized AD is unusual in neonates, but because AD 
is such a common problem, it is the most common 
cause of acquired or non-congenital erythroderma 
in infants (Fig. 2) (3). From the clinical point of 
view, in the first months of life AD is characterized 
by exudative lesions. There is considerable over-
lap between the manifestation of infantile sebor-
rheic dermatitis and AD, and some authors believe 
that infantile seborrheic dermatitis is a variant of 
AD (2,7). About 30% of cases of AD starting in the 
Figure 1. (a) Erythema and pustules in erythema 
toxicum neonatorum; (b) erythema toxicum neo-
natorum with numerous pustules.
Figure 2.  Atopic dermatitis, a more extensive dis-
tribution with pronounced pruritus.
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first months of life involve primarily the scalp with 
lesions resembling seborrheic dermatitis (2). 
Classic infantile AD involves the scalp, cheeks 
and extensor surfaces of the extremities, and does 
not appear until the infant is 2 to 3 months of age. 
Itching in children with AD is usually not apparent 
until 2 to 3 months of age (2,7). Typically, the dia-
per region is spared even in cases of widespread 
AD, as a result of the moist, occlusive environment 
caused by the diaper. AD may occasionally be 
complicated by a rare form of food hypersensitiv-
ity known as eosinophilic gastroenteritis, mostly to 
cow’s milk protein, with excessive loss of protein 
through the gastrointestinal tract (8).
When the distribution is generalized and the 
onset early, the diagnosis can be more difficult. 
In contrast to infants with severe metabolic or im-
mune disease, infants with AD usually grow and 
thrive normally, assuming the disease is recog-
nized and treated promptly (3).
Seborrheic dermatitis
Infantile seborrheic dermatitis typically pres-
ents during the first month of life. The character-
istic feature of infantile seborrheic dermatitis is in-
flammation, yellowish scaling on the scalp (cradle 
cap) with frequent involvement of the skinfolds of 
the neck, axillae, and groin (Fig. 3). The lesions 
are sometimes more infiltrated and resemble pso-
riasis. Progression to erythroderma is rare (9). 
A syndrome characterized by erythema, in-
filtration and desquamation in the seborrheic lo-
calization with rapid progression to erythroderma, 
accompanied by recurrent local and systemic 
infections, severe diarrhea and failure to thrive 
was called Leiner’s disease. It was considered to 
be caused by complement C5 deficiency or dys-
function (8). The term is no longer appropriate 
because it probably refers to a heterogeneous 
group of disorders (10). It has become clear, over 
the past decade, that Leiner’s disease is an “um-
brella phenotype” rather than a specific entity, and 
often applied to babies in whom the known causes 
of erythroderma have been excluded (2). 
Infants with erythroderma, failure to thrive and 
chronic diarrhea need thorough investigations, 
searching for the underlying cause of their disor-
der. In Leiner phenotype, many of the diseases 
need to be considered, especially immunodefi-
ciencies, Netherton’s syndrome and Omenn’s 
syndrome (3).
Psoriasis 
Congenital psoriasis, meaning psoriasis pres-
ent at birth or appearing during the neonatal period, 
is exceptional. Only 15 cases of congenital eryth-
rodermic psoriasis have been reported (11,12). 
Positive family history for psoriasis and human 
leukocyte antigen (HLA) B17 is found in more than 
half of the patients and their relatives (12). Con-
genital and neonatal erythrodermic psoriasis are 
among the most serious and difficult forms of pso-
riasis to treat. Clinical diagnosis is usually difficult, 
and many differential diagnoses should be consid-
ered, mainly congenital non-bullous ichthyosiform 
erythroderma (11). Most cases later develop clas-
sic erythematosquamous lesions (13).
Less than 1% of all cases of psoriasis occur in 
infants under 1 year of age (3). Infantile psoriasis 
may have similar clinical presentation as both seb-
orrheic and atopic dermatitis. Facial involvement 
may be more common in the infant, and the scalp, 
palms and soles may have diffuse erythema and 
scales. Psoriasis in infants often involves the diaper 
area because it develops in areas of injured skin 
(Koebner phenomenon), e.g., after prior irritant or 
candida diaper dermatitis (Fig. 4) (14). Cases of 
Figure 3.  Infantile seborrheic dermatitis with in-
volvement of the head, face, body folds and nap-
kin area.
Figure 4. Napkin psoriasis: psoriasiform confluent 
generalized lesions started in the napkin area. 
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infantile psoriasis may prove to be mild and oc-
casionally even clear completely as the child gets 
older. The prognosis of generalized erythrodermic 
or pustular psoriasis in infancy is more guarded, 
and treatment usually requires systemic retinoid 
therapy as well as supportive care (3).
diffuse cutaneous mastocytosis
It is a rare variant of mastocytosis that gener-
ally presents in the neonatal period.  The entire 
skin is heavily infiltrated with mast cells; the skin is 
thickened, lichenified and erythematous, and may 
have leathery appearance (8). Mild pressure or 
trauma to the skin induces mast cell release with 
urtication (Darier’s sign) that can progress to bulla 
formation (Fig. 5). In the first months of life, the 
condition can be dangerous and life threatening 
due to electrolyte and fluid loss (15). Bullous mani-
festations in mastocytosis occur only in the first two 
or three years of life. Blister formation may mimic 
staphylococcal scalded skin syndrome (16). To 
distinguish mastocytosis from vesicular and bul-
lous neonatal disorders, Darier’s sign and Tzanck 
smear should be performed. Systemic symptoms 
such as flushing attacks, respiratory difficulty and 
diarrhea are common. Rarely, infants may have 
extracutaneous mast cell infiltration (gastrointes-
tinal tract, bones, liver, spleen and lymph nodes). 
Systemic mastocytosis and mast cell leukemia are 
extremely rare in childhood. Mastocytosis tends to 
remit spontaneously, especially when it occurs in 
infancy or early childhood. Skin biopsy is diagnos-
tic with a dense, band-like infiltrate of mast cells 
in the upper dermis, which can be confirmed with 
Giemsa stain (3). 
Treatment is directed at alleviation of symp-
toms; H1- and H2-receptor antagonists, disodium 
cromoglycate and ketotifen (a stabilizer of mast 
cell membranes) are helpful. Particular foods and 
medicines can liberate histamine and should be 
restricted. Children with a history of anaphylaxis 
should be equipped with injectable adrenaline in 
the form of an Epi-Pen. Special care should be 
taken when these patients are to undergo anes-
thesia (8).
Ichthyosis
Hereditary ichthyoses are a large and heteroge-
neous group of disorders, which have in common 
rough, dry and scaly skin. Of the different types of 
ichthyosis, congenital non-bullous ichthyosiform 
erythroderma (CIE)/lamellar ichthyosis (LI) and 
bullous ichthyosiform erythroderma (bullous CIE) 
manifest at birth with variable degrees of erythro-
derma. CIE is characterized by fine white-gray-
ish scales and erythroderma, and LI manifests as 
generalized ichthyosis with large, dark, plate-like 
scales and an underlying mild or minimal erythe-
ma. At present, LI and CIE may be considered two 
polar ends of the clinical spectrum, caused by sev-
eral different genes and including many interme-
diate phenotypes (17,18). About 90% of patients 
present at birth as “collodion babies” with a glis-
tening membrane which envelopes the neonate 
and produces ectropion, eclabium and nasal ob-
struction (Fig. 6). 
Bullous CIE, also referred to as epidermo-
lytic hyperkeratosis (EH), presents with general-
ized erythema and superficial blisters that are 
frequently mistaken for staphylococcal scalded 
skin syndrome (SSSS) or epidermolysis bullosa. 
Figure 5. Diffuse cutaneous mastocytosis. The 
entire skin is erythematous, heavily infiltrated and 
thickened, Darier’s sign is positive with urtication 
and bullae formation.
Figure 6. Collodion baby with a generalized glis-
tening, taut membrane stretched over the entire 
skin, constricting band encircling the digit on the 
right hand. 
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These children later develop typical ichthyosiform 
hyperkeratosis. It is transmitted as an autosomal 
dominant trait with mutations in the genes encod-
ing keratin 1 and 10, however, spontaneous muta-
tions may account for approximately one-half of 
cases (2,18). 
Interestingly, some parents to the children with 
bullous CIE have had limited disease expression 
in the form of linear epidermal nevi with similar 
histology to EH. It has been proven that mosaic 
keratin 10 mutations give rise to an epidermo-
lytic epidermal nevus, whereas the presence of 
the mutation in all cells gives rise to bullous CIE. 
The mutation can involve other organs includ-
ing gonads. In patients with linear epidermolytic 
epidermal nevus, gonadal mosaicism may be re-
sponsible for transmission of the abnormality to 
the offspring, leading to diffuse skin involvement 
in the child. Therefore, it is important to do histo-
logic examination in all cases of linear epidermal 
nevus to look for EH. Patients with epidermolytic 
epidermal nevus should be informed on the pos-
sible risk of transmission of bullous CIE to the next 
generation (18-20).
netherton’s syndrome
Netherton’s syndrome (NS) is a rare autosomal 
recessive genodermatosis that is classified as an 
ichthyosiform syndrome. Infants affected with this 
disorder show a triad of generalized exfoliative 
dermatitis, sparse hair with trichorrhexis invagi-
nata (“bamboo hair”), and atopic features (Fig. 7). 
The main differential diagnosis is Omenn’s syn-
drome, but in practice a frequent misdiagnosis is 
generalized atopic dermatitis (2,10). Ichthyosiform 
erythroderma in NS is worst in infancy and tends 
to improve in later childhood. Ichthyosis linearis 
circumflexa, with its migrating, erythematous 
patches and fringe of double-edged scales, de-
velop after the age of 2 years (21). During the first 
year of life, patients with NS undergo a period of 
life threatening infections, hypernatremic dehydra-
tion, diarrhea and failure to thrive, with mortality of 
30%-40% during this period (2). Apart from raised 
total IgE and multiple positive specific IgE reac-
tions, there are no consistent immunologic abnor-
malities in NS (19,21).
Genetic linkage has been established to the 
mutation of SPINK-5 gene locus on chromosome 
5q31-32 encoding the serum protease inhibitor 
LEKTI (lymphoepithelial Kazal type inhibitor). It is 
absent or abnormally expressed on immunohisto-
chemistry staining in the stratum granulosum of 
patients with NS in comparison with normal skin 
(1,22). NS can be distinguished from neonatal 
graft-versus-host disease and Omenn’s syndrome 
by psoriasiform acanthosis, thickening of the base-
ment membrane, prominent dermal blood vessels, 
and dermal infiltrate in which lymphocytes and 
macrophages are represented equally (22). 
InFeCtIonS
Many perinatal or early neonatal infectious dis-
eases are associated with skin eruption present at 
birth or in the early neonatal period.
Staphylococcal scalded skin syndrome 
(SSSS) 
SSSS is a potentially life-threatening toxin-
mediated manifestation of localized infection with 
certain toxigenic strains of Staphylococcus aureus 
(mostly group II phage, types 71 and 55). Exfolia-
tive toxins (ET-A and ET-B) that have been char-
acterized as serine proteases cause the symp-
toms. SSSS is predominantly a disease of infancy 
and early childhood, with most cases seen before 
the age of 5 years due to renal immaturity and 
decreased toxin clearance, and the lack of immu-
nity to toxins in these age groups. Congenital and 
neonatal cases of SSSS following chorioamnion-
itis have been described (2,13,24). In generalized 
forms of SSSS, toxin diffuses from an infected fo-
cus (conjunctiva, umbilicus, nose, urine) and, in 
the absence of specific antitoxin antibody, spreads 
by hematogenous route to produce its widespread 
effects by cleaving a specific amino acid of des-
moglein 1 (8).  SSSS is an acantholytic intraepi-
dermal blistering process in which cleft appears in 
the granular layer just beneath the stratum corne-
Figure 7. Netherton’s syndrome: generalized des-
quamative erythroderma and alopecia in an infant 
with failure to thrive complicated by sepsis.
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um (2,8). Unlike other erythrodermas, in children 
with SSSS the onset is acute, accompanied by fe-
ver, systemic toxicity, and positive Nikolsky sign. 
The erythema generalizes rapidly and progresses 
to sloughing and erosions (Fig. 8). Although there 
is often periorificial accentuation, the staphylo-
coccal toxin requires keratinizing epithelium and 
therefore spares mucous membrane surfaces (3). 
Histopathology of the lesion distinguishes it from 
toxic epidermal necrolysis.
Staphyloderma pustulosa
Rarely a widespread form of staphylococcal 
pustulosis can acutely and rapidly develop in an 
otherwise healthy infant, resembling generalized 
candidiasis. Hundreds of 1-mm superficial pus-
tules within erythematous patches desquamate, 
leaving widespread areas of erythema and scales. 
Cultures grow Staphylococcus aureus and the 
disease clears rapidly with appropriate antibiotics 
(1,8).
Congenital and neonatal candidiasis
It is assumed that in congenital candidiasis the 
fetus has been infected in utero during the last 
days of pregnancy. Congenital candidiasis typi-
cally presents either at birth or within 48 hours of 
life with generalized erythema, vesicles, pustules, 
papules, and scaling (3,25). It spreads rapidly and 
often involves the umbilicus, palms and soles (Fig. 
9) (1). Candida albicans can also cause a diffuse 
burn-like erythema within the first 2 weeks of life in 
premature infants. The risk of extracutaneous dis-
ease and the prognosis depend on the gestational 
age and weight of the infant. In infants less than 
1500 g with either congenital or acquired general-
ized cutaneous candidiasis, there is a significant 
risk of disseminated disease, including involve-
ment of the lung, meninges, and urinary tract. An 
infant with a possible systemic candidiasis must 
be thoroughly evaluated as systemic infection 
presents a life threatening condition. After the 
blood, spinal fluid, and urine have been cultured, 
it is recommended to introduce systemic antifun-
gal agents (3,8,26). Differential diagnosis includes 
intrauterine herpes simplex virus infection, erythe-
ma toxicum neonatorum, pustular miliaria rubra, 
and neonatal pustular melanosis (3).
In the neonatal form of cutaneous candidiasis, 
the lesions usually start in the oral cavity or the 
napkin area and develop three to seven days after 
birth. Topical therapy with an antifungal cream is 
usually sufficient because dissemination does not 
develop in an immunocompetent infant (3,25).
Congenital herpes simplex infection 
Intrauterine variant of herpes simplex infection 
can present at birth with either isolated or diffuse 
Figure 8. Staphylococcal scaled skin syndrome 
(SSSS): accentuated erythema in the circumoral, 
neck and scrotal region with positive Nikolsky’s 
sign (flaccid blisters and erosions) in a high febrile 
child.
Figure 9. Neonatal candidiasis: generalized ery-
thema with scattered pustules and erythematous 
papules.
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erythema, and scaling or crusted erosions on an 
erythematous base. It may be difficult to recognize 
clinically because vesicles may not be present. 
This type of widespread involvement is generally 
associated with very severe neurologic disease. 
Multinucleated giant cells should be demonstrable 
on Tzanck smears of vesicular lesions (3).
Syphilis
Congenital syphilis may cause diffuse erythe-
ma and scaling. This presentation is most typically 
seen in infants at 6 to 8 weeks of age, in whom 
exposure to Treponema pallidum occurred either 
very late in pregnancy or at the time of delivery. 
Superficial erosions or bullae over the hands or 
feet of the newborn, together with a diffuse scaling 
dermatitis should alert to the possibility of syphilis. 
Infiltrated mucosal papules and plaques (condy-
lomata lata) are most often seen in the perianal 
region. Periosteal changes of long bones as well 
as hepatosplenomegaly, lymphadenopathy, ane-
mia and thrombocytopenia are additional features 
(3,27).
drug reaCtIonS
Drug induced erythrodermas in children are 
commonly observed with sulphonamides, iso-
niazid, streptomycin, NSAIDs, and antiepileptic 
drugs. If the incriminating drug(s) are withdrawn 
and symptomatic treatment instituted, these cases 
have an excellent prognosis (1).
toxic epidermal necrolysis
Toxic epidermal necrolysis (TEN) is an acute 
severe bullous cutaneous disease characterized 
by extensive areas of skin necrosis accompanied 
by a systemic toxic condition. TEN is usually a dis-
ease of adults and is less common in childhood. 
The vast majority (80%-95%) of children with TEN 
have a drug reaction implicated as the cause. Sul-
phonamides, anticonvulsants, non-steroidal anti-
inflammatory drugs (NSAIDs) and penicillins are 
most frequently implicated. Several cases of TEN 
in infants have been described in association with 
Klebsiella pneumoniae (28) and Staphylococcus 
aureus sepsis (8). In most children, TEN develops 
in the form of blistered erythematous patches and 
plaques that evolve within hours to extensive ar-
eas of skin necrosis, with loss of sheets of epider-
mis. About 90% of patients will have involvement 
of the mucosa with painful erosions and hemor-
rhagic crusts. TEN is a severe disease with a high 
mortality rate of 30% to 70% (29).
Differentiation from SSSS is necessary. High 
fever and occurrence in older children favor the 
diagnosis of TEN, whereas evidence of preceding 
rhinitis and localization to intertriginous and peri-
orificial areas, acutely tender skin and occurrence 
in newborns or infants suggest the diagnosis of 
SSSS. Definitive diagnosis depends on the histo-
logic location of the blister; in TEN the separation 
is subepidermal, and full-thickness epidermal ne-
crosis is noted (8).
metaboLIC/nutrItIonaL dISorderS
The diseases in this category need to be con-
sidered in an infant who is ill or not thriving, and the 
dermatitis begins in the periorificial area before it 
generalizes.  Although the etiologies of these dis-
orders differ, the clinical manifestations are strik-
ingly similar, possibly because there is a common 
link in the pathogenesis at the level of protein or 
keratin biosynthesis. Epidermal turnover is more 
rapid on mucous membranes, which could explain 
the periorificial predilection of many of these dis-
orders as well as profound diarrhea seen in some 
of them (8).
 acrodermatitis enteropathica
Zinc deficiency is a classic example of a nutri-
tional or metabolic cause of neonatal erythroder-
ma. Acrodermatitis enteropathica is an autosomal 
recessive disorder thought to be due to impaired 
intestinal absorption of zinc. The initial lesions are 
vesiculobullous, crusted or psoriasiform and de-
velop usually in the perioral and perianal areas. 
Skin lesions are accompanied by diarrhea, failure 
to thrive, alopecia, recurrent infection, photopho-
bia and irritability. Secondary infection of the skin 
with Candida is not uncommon (8). In addition to 
low serum zinc levels, serum alkaline phospha-
tase levels are also reduced, as this enzyme is 
zinc dependent (30). The signs and symptoms of 
acrodermatitis enteropathica can also appear in 
other disorders associated with secondary zinc 
deficiency, including malabsorption syndromes 
and long-term use of zinc-deficient parenteral nu-
trition (31). The response to zinc therapy is rapid 
and dramatic. 
An acrodermatitis-like symptom complex with 
perioral dermatitis, failure to thrive, diarrhea and 
low zinc concentrations has been reported in chil-
dren with acquired immune deficiency syndrome 
(AIDS) (32). 
Essential fatty acid deficiency
Essential fatty acids (EFA), such as linoleic and 
linolenic acids, must be supplied by the diet as the 
body cannot synthesize them. EFA deficiency can 
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be seen in individuals with severe fat malabsorp-
tion. EFA deficiency leads to increased suscepti-
bility to infection, growth impairment, and a char-
acteristic generalized and periorificial cutaneous 
eruption consisting of dry, thickened, erythema-
tous, desquamating plaques (8,31). 
Cystic fibrosis dermatitis
A well-known complication of cystic fibrosis 
(CF) is protein-energy malnutrition, characterized 
by hypoproteinemia, edema and anemia. Sweat 
chloride level is usually elevated. However, con-
firmation of the diagnosis is complicated by the 
fact that the sweat test can be falsely negative in 
edematous infants (33). 
Cutaneous manifestations of malnutrition are 
rare in patients with CF and have been attributed 
to deficiencies of protein, zinc and EFA, particu-
larly linoleic acid. Zinc and EFA have reciprocal 
metabolic interactions that alter both the produc-
tion of prostaglandins from linoleic acid and their 
subsequent metabolism (31).
Failure to thrive, hypoproteinemia, edema, and 
cutaneous eruption can be present before the 
onset of pulmonary and gastrointestinal symp-
toms and before the diagnosis of CF is confirmed 
(8,34). The clinical and histologic appearance of 
the rash in infants with CF most closely resembles 
acrodermatitis enteropathica. Infants with CF can 
develop widespread, scaly erythematous lesions 
as a manifestation of global malnutrition during the 
first 3 or 4 months of life (3). 
amino acid disorders 
In different amino acid disorders, dermatitis 
similar to acrodermatitis enteropathica can appear 
due to dietary over-restriction of branched-chain 
amino acids. Patients with maple syrup urine dis-
ease are unable to metabolize three branched-
chain amino acids: leucine, isoleucine and valine 
(3). A diet low in branched-chain amino acids is 
indicated. Overly strict adherence to this diet may 
result in deficiency of these amino acids and ex-
foliative erythroderma (8). Erythematous scaling 
eruption that becomes erosive begins primar-
ily in the periorificial distribution within days after 
initiating dietary therapy (35). Treatment requires 
diligent attention to dietary restriction so that suf-
ficient branched-chain amino acids are delivered 
(8). Presumably, adequate concentrations of 
amino acids are needed for normal keratinization 
(36). 
Similar eruptions have also been noted in neo-
natal citrullinemia and carbamoyl phosphate syn-
thetase deficiency, methylmalonic and propionic 
acidemia (3,36,37). 
Methylmalonic and propionic acidemia may 
be associated with a variety of cutaneous mani-
festations such as superficial scalded skin, pso-
riasiform desquamation after metabolic decom-
pensation, and chronic periorificial acrodermatitis 
enteropathica-like dermatitis (36). 
Multiple carboxylase deficiency
Biotin-responsive multiple carboxylase defi-
ciency (MCD) is a potentially lethal disorder which 
may manifest in early infancy with metabolic aci-
dosis, central nervous system dysfunction, and 
recurrent infections. MCD is an autosomal reces-
sive disorder of metabolism in which the function 
of mitochondrial biotin-dependent carboxylase en-
zymes are impaired (propionyl CoA carboxylase, 
β-methylcrotonyl CoA carboxylase, and pyruvate 
carboxylase) with non-functional branched-chain 
amino acid and carbohydrate metabolism (38).
The neonatal form of MCD presents in the first 
weeks of life, due to deficient holocarboxylase 
synthetase enzyme, with sharply margined der-
matitis on the scalp, eyebrows and eyelashes that 
spreads to the perioral, perianal and other flexural 
areas. Secondary candidiasis is common. The hair 
thins and there can be associated blepharitis and 
keratoconjunctivitis with photophobia. If untreated, 
profound lactic acidosis, ketosis, and death result. 
Early recognition and therapy with oral biotin may 
completely reverse all of the manifestations of the 
disorder (6,38).
The juvenile form is milder than the neonatal 
form and presents between the ages of 3 weeks 
and 2 years. It is caused by total or partial defi-
ciency of the enzyme biotinidase. Dermatologic 
symptoms are the same as in the neonatal form of 
MCD. These children also develop hearing loss, 
seizures, ataxia and coma (6,38,39). Immediate 
treatment and lifelong management using phar-
macological doses of biotin supplements may pre-
vent many of these complications.
Immune dISorderS
Because of the protective effect of maternal im-
munity, congenital immunodeficiency syndromes 
are rarely symptomatic at birth. Graft-versus-host 
reaction from maternal lymphocyte engraftment 
may, however, occur even during intrauterine de-
velopment.   
graft-versus-host disease (gVHd)
GVHD is seen mainly in children with T cell 
immunodeficiency, but can occur in immunocom-
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petent newborns as the result of transplacental 
passage of maternal lymphocytes or in the post-
natal period (exchange transfusions) (2). Clinical 
manifestations include fever, morbilliform rash that 
gradually progresses to erythroderma, eosino-
philia, lymphocytosis, hepatosplenomegaly, and 
lymphadenopathy (4,8,40). The diagnosis should 
be suspected in any young infant with erythro-
derma and frequent infections, chronic diarrhea, 
and failure to thrive.  Clinical presentation may re-
semble Omenn‘s syndrome, but the skin eruption 
is usually less eczematous in GVHD. Infiltration 
of activated cytotoxic T cells into the skin is the 
common pathogenic mechanism for both skin le-
sions (41). In contrast, in the immunocompetent 
newborn with a small number of transferred cells, 
clinical symptoms are minimal and may involve 
only transient macular rash (2).
Histologic examination usually reveals signifi-
cant lymphocytic infiltration and keratinocytic ne-
crosis with satellite lymphocytes. These findings, 
however, are not specific for GVHD since similar 
changes are found in Omenn‘s syndrome (18). 
Karyotyping and histocompatibility typing can help 
detect maternal engraftment in an immunodeficient 
infant, which will suggest the diagnosis of GVHD 
(41). Histology findings can rule out Netherton‘s 
syndrome and CIE as other possible causes of 
neonatal and infantile erythroderma. 
Severe combined immunodeficiency
Severe combined immunodeficiency (SCID) 
represents a heterogeneous group of genetic 
disorders characterized by a profound defect in 
T cell differentiation or function, accompanied by 
secondary B cell depletion or dysfunction (42). It 
is inherited as an autosomal dominant or X-linked 
recessive trait. The impaired cellular and humoral 
immunity predispose these infants to a variety of 
serious infections and sometimes to the develop-
ment of GVHD due to engraftment of transplacen-
tally acquired maternal T cells (1). The main clini-
cal manifestations of SCID include predisposition 
to infections, growth retardation, and chronic di-
arrhea. Cutaneous manifestations include muco-
cutaneous infections, viral exanthemas and, most 
importantly, acute GVHD which usually occurs 
within the first months of life (Fig. 10) (43,44).
omenn’s syndrome/familial reticuloendo-
theliosis with eosinophilia
Omenn’s syndrome is a rare autosomal reces-
sive combined immunodeficiency. Although the 
condition is primarily due to T-cell dysregulation, 
both humoral and cellular immune defects are 
seen. A gene defect has been identified that maps 
to chromosome 11 (3, 41).
The etiology of Omenn’s syndrome is unknown, 
however, unlike other forms of SCID, patients with 
Omenn’s syndrome have activated T lymphocytes 
in their circulation capable of non-MHC restricted 
cytotoxic function (41). It is characterized by exfo-
liative erythroderma with the onset at birth or in the 
early neonatal period. It is associated with diffuse 
alopecia, pronounced lymphadenopathy, hepa-
tosplenomegaly, recurrent infections, and failure 
to thrive (2). Marked leukocytosis, eosinophilia, 
anemia, elevated serum IgE levels, hypogamma-
globulinemia and depressed T-cell immunity are 
other characteristics. Skin biopsy may confirm 
the diagnosis and help in differentiating it from 
Netherton’s syndrome. Keratinocyte necrosis with 
satellite lymphocytes and significant lymphocytic 
or eosinophilic infiltration of the skin are highly 
suggestive of an immnodeficiency syndrome (10). 
Although it is mostly fatal, cyclosporine and bone 
marrow transplantation can be effective therapies 
(1,3,8).
Hypogammaglobulinemia
Patients with hypogammaglobulinemia can 
present with neonatal erythroderma. An infant 
who is apparently normal at birth subsequently 
develops fever, diarrhea and rapidly progressive 
generalized exfoliative dermatitis (erythroderma). 
Monthly replenishment by intravenous infusion of 
gammaglobulins alleviates fever and erythema 
(1,8,40).
Figure 10. Graft-versus-host disease that devel-
oped in an 11-month-old infant with severe com-
bined immunodeficiency (SCID) after allogeneic 
bone marrow transplantation.
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management oF CHILdren wItH neo-
nataL and InFantILe erytHroderma
Irrespective of its cause, neonatal and infantile 
erythroderma is a potentially life threatening con-
dition. Erythrodermic neonates and infants are at 
a risk of hypernatremic dehydration and hyper- or 
hypopyrexia. These infants need a warm, humid 
environment to minimize their metabolic demands 
(3). Maintaining adequate oral or parenteral fluid 
intake and monitoring serum electrolytes are 
therefore mandatory. Topical application of emol-
lients, such as white paraffin, hydrates the skin 
and prevents fissuring. Blisters and erosions, seen 
in bullous ichthyosiform erythroderma, SSSS, and 
cutaneous mastocytosis, should be treated with a 
topical astringent, such as 0.01% potassium per-
manganate soaks, and systemic antibiotics should 
be given if necessary. As transcutaneous absorp-
tion is profoundly increased, additives such as sal-
icylic acid or lactic acid should be strictly avoided 
in the young infant, and topical steroids are to be 
used cautiously and only after the establishment 
of a diagnosis warranting their use (2).
 
ConCLuSIon
In neonates and infants numerous diseases 
can present with erythroderma. These can be 
transient, benign dermatoses, primary cutaneous 
diseases, however, more serious infectious, meta-
bolic and immune diseases should also be con-
sidered. Recognition of these diseases, i.e. early 
and precise diagnosis is important for it can spare 
a healthy child with transient, benign dermatosis 
from unnecessary or invasive evaluation, antibi-
otic treatment and hospitalization. On the other 
hand, recognition of potentially serious diseases 
that demand early treatment is mandatory. Delay 
in the establishment of the correct diagnosis can 
be fatal. Differential diagnosis of erythroderma is a 
multi-step procedure that involves clinical assess-
ment, knowledge of any relevant family history, 
and certain laboratory investigations.  
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